The Multibillion-Dollar Race for Gene Therapy Manufacturing Is On [The Motley Fool]
Novartis AG (NVS)
Last novartis ag earnings: 4/28 01:00 am
Check Earnings Report
US:NYSE Investor Relations:
novartis.com/investors
Company Research
Source: The Motley Fool
The Multibillion-Dollar Race for Gene Therapy Manufacturing Is On Gene therapy developers might steal all of the headlines, but manufacturing is likely to be the more lucrative investing opportunity -- for both companies and investors. Gene therapy, a promising therapeutic approach that corrects disease-causing genetic errors, has spurred an arms race among the world's largest pharmaceutical companies. Novartis ( NYSE:NVS ) announced the acquisition of AxeVis for a whopping $8.7 billion in 2018. Roche ( NASDAQOTH:RHHBY ) agreed to acquire gene therapy developer Spark Therapeutics for $4.8 billion in early 2019. One week later, Biogen ( NASDAQ:BIIB ) joined the party by pledging $800 million to gobble up Nightstar Therapeutics . Gene therapy stocks soared on the frenzy, and many have held on to deliver impressive gains since the beginning of the year. But the arms race isn't what it appears. True, Novartis and its peers are eyeing the obvious financial opportunity to sell correctiv
Show less
Read more
Impact Snapshot
Event Time:
NVS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVS alerts
High impacting Novartis AG news events
Weekly update
A roundup of the hottest topics
NVS
News
- UPDATE 2-Novartis to buy radiology drug specialist Mariana for $1 billion [Yahoo! Finance]Yahoo! Finance
- Novartis to buy Mariana Oncology for $1B upfront [Seeking Alpha]Seeking Alpha
- Mariana Oncology to be Acquired by Novartis to Advance Precision Radiopharmaceuticals to Treat Cancer [Yahoo! Finance]Yahoo! Finance
- The Global Market for Smart Inhalers, 2018-2023 and 2024-2033 - Novartis, AstraZeneca, GlaxoSmithKline, 3M Health Care, and Boehringer Ingelheim International Dominate the $1.62 Billion Industry [Yahoo! Finance]Yahoo! Finance
- Ikerian AG, Parent Company of RetinAI U.S. Inc. Announces Final Close of USD 6.18M (CHF 5.65M) Series A Extension Financing [Yahoo! Finance]Yahoo! Finance
NVS
Earnings
- 4/23/24 - Beat
NVS
Sec Filings
- 4/23/24 - Form 6-K
- 2/15/24 - Form S-8
- 2/2/24 - Form SC
- NVS's page on the SEC website